NeoGenomics, Inc.
(NASDAQ : NEO)

( )
NEO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
DVADaVita, Inc. 6.83%76.913.1%$160.76m
GHGuardant Health, Inc. 0.86%64.530.0%$78.64m
CHEChemed Corp. 4.88%446.9710.0%$66.76m
AMEDAmedisys, Inc. 5.79%184.5511.5%$63.72m
LHCGLHC Group, Inc. 1.61%130.882.9%$56.10m
NVTAInvitae Corp. 6.11%13.552.5%$51.67m
ACHCAcadia Healthcare Co., Inc. 17.54%21.9127.2%$38.89m
NTRANatera, Inc. 5.10%31.301.3%$37.37m
SDCSmileDirectClub, Inc. 7.67%4.350.0%$33.72m
NEONeoGenomics, Inc. 5.09%26.226.0%$29.02m
ENSGThe Ensign Group, Inc. 7.04%37.115.8%$22.69m
MDMEDNAX, Inc. 17.24%14.0111.2%$22.69m
FMSFresenius Medical Care AG & Co. KGaA 1.36%34.280.1%$20.08m
ONEM1Life Healthcare, Inc. -3.51%18.440.0%$20.02m
TVTYTivity Health, Inc. 11.21%6.259.0%$18.00m

Company Profile

NeoGenomics, Inc. is a clinical laboratory company, which specializes in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.